Literature DB >> 15317711

Subthreshold micropulse diode laser treatment in diabetic macular oedema.

M L Laursen1, F Moeller, B Sander, A K Sjoelie.   

Abstract

BACKGROUND/AIM: Enlargement of laser scars after retinal argon laser photocoagulation can give rise to deterioration in visual acuity. Subthreshold micropulse diode laser may decrease this risk. The aim of this study was to compare the effectiveness of subthreshold micropulse diode laser (810 nm) and conventional argon laser (514 nm) photocoagulation for the treatment of clinically significant macular oedema in diabetic patients.
METHODS: 23 eyes of 16 patients were randomised to either treatment. Follow up was conducted for a minimum of 5 months. Changes in visual acuity and macular oedema measured by optical coherence tomography were examined.
RESULTS: Visual acuity remained stable in all treatment groups throughout the observation period. Changes in retinal thickness were small both foveally and perifoveally. In patients with focal macular oedema a significant reduction in retinal thickness (9% approximately -26 microm, p = 0.02) was seen foveally 3 months after diode laser photocoagulation.
CONCLUSION: Subthreshold micropulse diode laser and conventional argon laser treatment showed an equally good effect on visual acuity. Subthreshold micropulse diode laser showed a stabilising or even improving effect on macular oedema. The combination of primary diode laser and supplementary argon laser might be particularly favourable in reducing diabetic macular oedema.

Entities:  

Mesh:

Year:  2004        PMID: 15317711      PMCID: PMC1772323          DOI: 10.1136/bjo.2003.040949

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  35 in total

1.  Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema.

Authors:  R J Olk
Journal:  Ophthalmology       Date:  1990-09       Impact factor: 12.079

2.  Submacular fibrosis after photocoagulation for diabetic macular edema.

Authors:  D P Han; W F Mieler; T C Burton
Journal:  Am J Ophthalmol       Date:  1992-05-15       Impact factor: 5.258

3.  Choroidal neovascularization after laser photocoagulation for diabetic macular edema.

Authors:  H Lewis; A P Schachat; M H Haimann; J A Haller; P Quinlan; M A von Fricken; S L Fine; R P Murphy
Journal:  Ophthalmology       Date:  1990-04       Impact factor: 12.079

4.  Diode laser (810 nm) versus argon green (514 nm) modified grid photocoagulation for diffuse diabetic macular edema.

Authors:  L Akduman; R J Olk
Journal:  Ophthalmology       Date:  1997-09       Impact factor: 12.079

5.  Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group.

Authors:  D S Fong; P P Segal; F Myers; F L Ferris; L D Hubbard; M D Davis
Journal:  Arch Ophthalmol       Date:  1997-07

6.  The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser.

Authors:  T R Friberg; E C Karatza
Journal:  Ophthalmology       Date:  1997-12       Impact factor: 12.079

7.  Sub-pigment epithelial membranes after photocoagulation for diabetic macular edema.

Authors:  B K Rutledge; I H Wallow; G L Poulsen
Journal:  Arch Ophthalmol       Date:  1993-05

8.  Subretinal fibrosis after laser photocoagulation for diabetic macular edema.

Authors:  D R Guyer; D J D'Amico; C W Smith
Journal:  Am J Ophthalmol       Date:  1992-06-15       Impact factor: 5.258

9.  Quantitative assessment of macular edema with optical coherence tomography.

Authors:  M R Hee; C A Puliafito; C Wong; J S Duker; E Reichel; B Rutledge; J S Schuman; E A Swanson; J G Fujimoto
Journal:  Arch Ophthalmol       Date:  1995-08

10.  Diode laser photocoagulation for diabetic macular oedema.

Authors:  M W Ulbig; D A McHugh; A M Hamilton
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

View more
  51 in total

1.  Comparative efficacy of pure yellow (577-nm) and 810-nm subthreshold micropulse laser photocoagulation combined with yellow (561-577-nm) direct photocoagulation for diabetic macular edema.

Authors:  Keiji Inagaki; Kishiko Ohkoshi; Sachiko Ohde; Gautam A Deshpande; Nobuyuki Ebihara; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2014-11-14       Impact factor: 2.447

Review 2.  Retinal light toxicity.

Authors:  P N Youssef; N Sheibani; D M Albert
Journal:  Eye (Lond)       Date:  2010-10-29       Impact factor: 3.775

3.  Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).

Authors:  Clement K Chan; Atul Jain; Srinivas Sadda; Neeta Varshney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

4.  Real-world outcomes of two-year Conbercept therapy for diabetic macular edema.

Authors:  Yong Cheng; Li Yuan; Ming-Wei Zhao; Tong Qian
Journal:  Int J Ophthalmol       Date:  2021-03-18       Impact factor: 1.779

5.  Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy.

Authors:  Ahmad Mirshahi; Alireza Lashay; Mehdi Roozbahani; Masoud Aghsaei Fard; Saber Molaie; Meysam Mireshghi; Mohamad Mehdi Zaferani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-11       Impact factor: 3.117

6.  Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema.

Authors:  Farzin Forooghian; Paul F Stetson; Scott A Meyer; Emily Y Chew; Wai T Wong; Catherine Cukras; Catherine B Meyerle; Frederick L Ferris
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

7.  Micropulse and continuous wave diode retinal photocoagulation: visible and subvisible lesion parameters.

Authors:  T J Desmettre; S R Mordon; D M Buzawa; M A Mainster
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

8.  Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd P Aiello; Neil M Bressler; Susan B Bressler; Ronald P Danis; Matthew D Davis; Frederick L Ferris; Suber S Huang; Peter K Kaiser; Craig Kollman; Srinavas Sadda; Ingrid U Scott; Haijing Qin
Journal:  Ophthalmology       Date:  2008-08       Impact factor: 12.079

9.  Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.

Authors:  Neil M Bressler; Allison R Edwards; Andrew N Antoszyk; Roy W Beck; David J Browning; Antonio P Ciardella; Ronald P Danis; Michael J Elman; Scott M Friedman; Adam R Glassman; Jeffrey G Gross; Helen K Li; Timothy J Murtha; Thomas W Stone; Jennifer K Sun
Journal:  Am J Ophthalmol       Date:  2008-02-21       Impact factor: 5.258

10.  Müller cell activation, proliferation and migration following laser injury.

Authors:  Mark A Tackenberg; Budd A Tucker; Jesse S Swift; Caihui Jiang; Stephen Redenti; Kenneth P Greenberg; John G Flannery; Andreas Reichenbach; Michael J Young
Journal:  Mol Vis       Date:  2009-09-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.